PZFVX
Price
$23.94
Change
-$0.07 (-0.29%)
Updated
Jun 5 closing price
Net Assets
598.03M
RMEBX
Price
$57.64
Change
-$0.04 (-0.07%)
Updated
Jun 5 closing price
Net Assets
105.31B
Interact to see
Advertisement

PZFVX vs RMEBX

Header iconPZFVX vs RMEBX Comparison
Open Charts PZFVX vs RMEBXBanner chart's image
JHancock Classic Value A
Price$23.94
Change-$0.07 (-0.29%)
VolumeN/A
Net Assets598.03M
American Funds American Mutual R2E
Price$57.64
Change-$0.04 (-0.07%)
VolumeN/A
Net Assets105.31B
PZFVX vs RMEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PZFVX vs. RMEBX commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PZFVX is a Buy and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 105B vs. PZFVX (598M). PZFVX pays higher dividends than RMEBX: PZFVX (2.63) vs RMEBX (1.16). PZFVX was incepted earlier than RMEBX: PZFVX (29 years) vs RMEBX (11 years). PZFVX (1.16) is less costly to investors than RMEBX (1.07). RMEBX is a more actively managed with annual turnover of: 31.00 vs. PZFVX (29.00). RMEBX has a lower initial minimum investment than PZFVX: RMEBX (250) vs PZFVX (1000). RMEBX annual gain was more profitable for investors over the last year : 8.30 vs. PZFVX (-29.27). RMEBX return over 5 years is better than : 49.85 vs. PZFVX (-4.68).
PZFVXRMEBXPZFVX / RMEBX
Total Expense Ratio1.151.07107%
Annual Report Gross Expense Ratio1.161.07108%
Fund Existence29 years11 years-
Gain YTD1.9975.34937%
Front Load5%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets598M105B1%
Annual Yield % from dividends2.631.16227%
Returns for 1 year-29.278.30-352%
Returns for 3 years-37.7517.96-210%
Returns for 5 years-4.6849.85-9%
Returns for 10 years-1.1568.21-2%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VERV5.720.43
+8.22%
Verve Therapeutics
VRNT18.780.97
+5.45%
Verint Systems
CHRS0.80N/A
+0.48%
Coherus Oncology Inc
CHSCN25.15-0.05
-0.20%
CHS
PRI265.13-2.99
-1.12%
PRIMERICA